Genetically engineered Tobacco mosaic virus as nanoparticle vaccines

Expert Review of Vaccines

Volumn 7, Issue 1, 2008, Pages 33-41

  McCormick, Alison A ^a   Palmer, Kenneth E ^b  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presenting cell; Epitope; Innate immunity; Nanoparticle; Particulate antigen; Reassembly; Tobacco mosaic virus; Tobamovirus

Indexed keywords

ADENOVIRUS VACCINE; ADENOVIRUS VECTOR; CHOLERA VACCINE; CYTOKINE; DOUBLE STRANDED RNA; GENE PRODUCT; IMMUNOGLOBULIN A ANTIBODY; INFLUENZA VACCINE; LIVE VACCINE; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; RABIES VACCINE; RECOMBINANT PROTEIN; REOVIRUS VACCINE; RETINOIC ACID INDUCIBLE PROTEIN I; SIGMA FACTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TYPHOID VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ABSENCE OF SIDE EFFECTS; ACUTE RESPIRATORY TRACT DISEASE; ADAPTIVE IMMUNITY; ADENOVIRUS; ADENOVIRUS 1; ADENOVIRUS 2; ADENOVIRUS 21; ADENOVIRUS 5; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN RECOGNITION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL TRACT; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; INTESTINE; MEDICAL TECHNOLOGY; MILITARY MEDICINE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RABIES; REVIEW; TRANSGENE; VACCINATION; VIRUS NEUTRALIZATION; VIRUS PNEUMONIA; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS SHEDDING;

ANTIGENS, VIRAL; CYSTEINE; GENETIC ENGINEERING; GREEN FLUORESCENT PROTEINS; IMMUNITY, CELLULAR; LYSINE; NANOPARTICLES; TOBACCO MOSAIC VIRUS; VACCINES;

EID: 40549102456     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.1.33     Document Type: Review

References (54)